{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:58:10Z","timestamp":1757779090775},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00292-005-0808-8","type":"journal-article","created":{"date-parts":[[2005,12,14]],"date-time":"2005-12-14T12:34:29Z","timestamp":1134563669000},"page":"27-32","source":"Crossref","is-referenced-by-count":5,"title":["Endometriumver\u00e4nderungen nach Tamoxifen-Therapie"],"prefix":"10.1007","volume":"27","author":[{"given":"D.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"808_CR1","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2000.18.20.3459","volume":"18","author":"Barakat","year":"2000","unstructured":"Barakat RR, Gilewski TA, Almadrones L et al. (2000) Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol 18:3459\u20133463","journal-title":"J Clin Oncol"},{"key":"808_CR2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","volume":"356","author":"Bergman","year":"2000","unstructured":"Bergman L, Beelen ML, Gallee MP et al. (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres\u2018 ALERT Group (Assessment of Liver and Endometrial cancer Risk following Tamoxifen). Lancet 356:881\u2013887","journal-title":"Lancet"},{"key":"808_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0029-7844(97)00591-7","volume":"91","author":"Berliere","year":"1998","unstructured":"Berliere M, Charles A, Galant C, Donnez J (1998) Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol 91:40\u201344","journal-title":"Obstet Gynecol"},{"key":"808_CR4","first-page":"1926","volume":"129","author":"Burckhardt","year":"1999","unstructured":"Burckhardt P (1999) Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy. Schweiz Med Wochenschr 129:1926\u20131930","journal-title":"Schweiz Med Wochenschr"},{"key":"808_CR5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","volume":"94","author":"Cohen","year":"2004","unstructured":"Cohen I (2004) Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94:256\u2013266","journal-title":"Gynecol Oncol"},{"key":"808_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-199501000-00003","volume":"14","author":"Dallenbach-Hellweg","year":"1995","unstructured":"Dallenbach-Hellweg G, Hahn U (1995) Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens. Int J Gynecol Pathol 14:7\u201315","journal-title":"Int J Gynecol Pathol"},{"key":"808_CR7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004040050276","volume":"263","author":"Dallenbach-Hellweg","year":"2000","unstructured":"Dallenbach-Hellweg G, Schmidt D, Hellberg P et al. (2000) The endometrium in breast cancer patients on tamoxifen. Arch Gynecol Obstet 263:170\u2013177","journal-title":"Arch Gynecol Obstet"},{"key":"808_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/gyno.2000.5859","volume":"78","author":"Deligdisch","year":"2000","unstructured":"Deligdisch L, Kalir T, Cohen CJ et al. (2000) Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 78:181\u2013186","journal-title":"Gynecol Oncol"},{"key":"808_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","volume":"86","author":"Fisher","year":"1994","unstructured":"Fisher B, Costantino JP, Redmond CK et al. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527\u2013537","journal-title":"J Natl Cancer Inst"},{"key":"808_CR10","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/cncr.11728","volume":"98","author":"Hachisuga","year":"2003","unstructured":"Hachisuga T, Miyakawa T, Tsujioka H et al. (2003) K-ras mutation in tamoxifen-related endometrial polyps. Cancer 98:1890\u20131897","journal-title":"Cancer"},{"key":"808_CR11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2214\/ajr.168.3.9057510","volume":"168","author":"Hann","year":"1997","unstructured":"Hann LE, Giess CS, Bach AM et al. (1997) Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR Am J Roentgenol 168:657\u2013661","journal-title":"AJR Am J Roentgenol"},{"key":"808_CR12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.SMJ.0000051146.93190.4A","volume":"96","author":"Haskell","year":"2003","unstructured":"Haskell SG (2003) Selective estrogen receptor modulators. South Med J 96:469\u2013476","journal-title":"South Med J"},{"key":"808_CR13","first-page":"237","volume":"69","author":"Killackey","year":"1985","unstructured":"Killackey MA, Hakes TB, Pierce VK (1985) Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treat Rep 69:237\u2013238","journal-title":"Cancer Treat Rep"},{"key":"808_CR14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/gyno.1998.5087","volume":"70","author":"Kommoss","year":"1998","unstructured":"Kommoss F, Karck U, Prompeler H et al. (1998) Steroid receptor expression in endometria from women treated with tamoxifen. Gynecol Oncol 70:188\u2013191","journal-title":"Gynecol Oncol"},{"key":"808_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1525-1438.2000.010004280.x","volume":"10","author":"McCluggage","year":"2000","unstructured":"McCluggage WG, Abdulkader M, Price JH et al. (2000) Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases. Int J Gynecol Cancer 10:280\u2013284","journal-title":"Int J Gynecol Cancer"},{"key":"808_CR16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0046-8177(03)00335-6","volume":"34","author":"McCluggage","year":"2003","unstructured":"McCluggage WG, Sumathi VP, McManus DT (2003) Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy. Hum Pathol 34:939\u2013943","journal-title":"Hum Pathol"},{"key":"808_CR17","first-page":"138","volume":"8","author":"Remmele","year":"1987","unstructured":"Remmele W, Stegner H (1987) Vorschlag zur einheitlichen Definierung eines immunreaktiven Score (IRS) f\u00fcr den immunhistochemischen \u00d6strogenrezeptornachweis (ER-ICA) im Mammakarzinom. Pathologe 8:138\u2013140","journal-title":"Pathologe"},{"key":"808_CR18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jcb.240590924","volume":"23","author":"Silva","year":"1995","unstructured":"Silva EG, Tornos C, Malpica A, Mitchell MF (1995) Uterine neoplasms in patients treated with tamoxifen. J Cell Biochem Suppl 23:179\u2013183","journal-title":"J Cell Biochem Suppl"},{"key":"808_CR19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0301-2115(01)00516-4","volume":"101","author":"Vosse","year":"2002","unstructured":"Vosse M, Renard F, Coibion M et al. (2002) Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring. Eur J Obstet Gynecol Reprod Biol 101:58\u201363","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-005-0808-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-005-0808-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-005-0808-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:00:55Z","timestamp":1559041255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-005-0808-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s00292-005-0808-8","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}